In 2019, we reported that KRAS mutant cancer cells with a gain-of-function p53 mutation can “educate” adjacent CAFs via short and long range NFκB/TNFα signalling, driving the establishment of a pro-metastatic and chemoresistant environment by secreting perlecan (a basement membrane protein) [29] (Figure 2b). Here, KRAS is linked to cancer.